Randomized Trial of Anticoagulation Guided by Remote Rhythm Monitoring in Patients With Implanted Cardioverter-Defibrillator and Resynchronization Devices - IMPACT


Patients with paroxysmal atrial fibrillation (AF)/atrial tachycardia (AT) have a thromboembolic risk that is directly correlated to its duration and burden. Implanted cardioverter-defibrillator (ICD) and resynchronization (CRT-D) devices have the ability to discriminate atrial tachyarrhythmias (ATs). The current trial sought to study the safety and efficacy of remote monitoring with these implanted devices in the management decision of anticoagulation for AT.